Asthma Case Presentation

37,965 views 30 slides Mar 30, 2017
Slide 1
Slide 1 of 30
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30

About This Presentation

What is asthma?
can it be prevented?
what are treatment options?


Slide Content

Dr Zain Ul Abidin Bahawal Victoria Hospital Bahawalpur [email protected] ASTHMA

Definition It is a disease characterized by recurrent attacks of breathlessness and wheezing , which vary in severity and frequency from person to person. In an individual, they may occur from hour to hour and day to day.

Causes AHR : airway hyper-reactivity is the main cause of asthma Airway hyper reactivity Exaggerated response of the airways for a stimulus which triggers little or no response in normal people

Other Contributing Factors 1 .allergan exposure 2 .dietary deficiency of antioxidants 3.aspirin ( lipoxigenase pathway is intact) 4.other drugs(OCP, cholinergic drugs,B blockers) 5.exercise (non humidified inhaled air is a trigger)

Pathogenesis 3 basic characteristics identified are; A. airway hyper reactivity B. airway inflamation C. airway obstruction

Constricted airways in asthma

Types of asthma 1.extrinsic (atopic) 2.Intrinsic or adult onset (can be atopic or non atopic) 3.exercise induced 4.child onset (atopic) 5.Occupational 6.aspirin induced( lipoxigenase pathway causes bronchoconstriction ) 7.nocturnal 8.pregnancy

Clinical presentation The patient will be presenting the following symptoms RECURRENT EPISODES OF Breathlessnes Wheezing Chest tightness Cough (may be the only presentation)

Diurnal pattern Characteristically there is a diurnal pattern . Symptoms worsen in the early morning

Nocturnal asthma If the condition is not properly managed ,there would be nocturnal asthma Cough and wheezing disturbing sleep

DIAGNOSIS

Diagnosis Mostly clinical diagnosis Symptoms. Recurrent Episodes of breathlessness Coughing Wheezing Chest tightness

Signs of asthma Signs Rapid shallow breathing Pallor or cyanosis due to obstruction Hyperexpansion of the chest Tachycardia for the compensation Tachypnea Frequent pausing to catch breath while talking

Investigations Routine pulmonary function test Normal or signs of obstruction Dispropotionately Decreased FEV /FVC + hyperinflation(inc VC) and improvement with bronchodilators

Spirometry

Investigations Chest X-ray Normal in asymptomatic patients Hyperinflation in symptomatic patients

Hyperinflation of lungs

Investigations Peak Flow Measurements Diurnal variation in PEF of more than 20% is considered diagnostic

Investigations Skin Tests to establish atopy

Investigations Blood tests Eosinophila and increased IgE levels in atopy

Management

Management(stepwise approach) Step One . For patients with mild intermittent asthma _symptoms less than once a week for 3 mnths _less than 2 nocturnal episodes Occasional inhalational use of short acting B adrenoreceptor agonists Eg salbutamol or terbatuline

Management Step Two .introduction of regular preventor therapy.. Inhaled B agonists + Inhaled corticosteroids ( eg beclomethasone ) In patients with _ exacebration of asthma in last 2 yrs _uses B agonist inhaler 3 times a week or more _reports symptoms three times a week or more _presentation of nocturnal asthma

Management Step 3. add on therapy For patients who are not controlled even by ICS. Long acting B agonists are added eg salmeterol,formoterol . Inhaled B agonists + Inhaled corticosteroids + Long acting B agonists

Management Step Four. Addition of a 4 th drug (if step 3 is not effective) Nasal corticosteroids are added Inhaled B agonists + Inhaled corticosteroids + Long acting B agonists + nasal corticosteroids Step Five. Continuous or frequent use of oral Steroids Prednisolone therapy is prescribed at the lowest amount to control symptoms

Management Step Down Therapy Once asthma control is established,the dose of ICS should be titrated. Decreasing the dose by 25-50% every 3 months is the reasonable strategy for most patients

Management of acute severe asthma Acute severe asthma PEF 33-50% Respiratory rate 25/min or more Heart rate 110/min or more Inability to complete sentence in 1 breathe Management 1.Oxygen at high concentration (humidified if possible) 2.High doses of Inhaled bronchodilators (via nebulizer) 3.Systemic corticosteroids 4.Intravenous fluids

Oxygen therapy